Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-19 5:02 pm Sale | 13G | CYTOKINETICS INC CYTK | Eastern Capital LTD | 3,062,748 4.3% | -544,781 (-15.10%) | View |
| 2021-02-16 3:16 pm Sale | 13G | CYTOKINETICS INC CYTK | Point72 Asset Management L.P. | 1,176,653 1.7% | -1,855,196 (-61.19%) | View |
| 2021-02-10 10:46 am Purchase | 13G | CYTOKINETICS INC CYTK | VANGUARD GROUP INC | 4,821,990 6.81% | 276,000 (+6.07%) | View |
| 2021-02-08 10:07 am Purchase | 13G | CYTOKINETICS INC CYTK | STATE STREET CORP STT | 4,640,923 6.56% | 2,724,961 (+142.22%) | View |
| 2021-01-25 4:50 pm Purchase | 13G | CYTOKINETICS INC CYTK | BlackRock Inc. BLK | 11,611,079 16.4% | 2,050,477 (+21.45%) | View |
| 2021-01-13 4:56 pm Sale | 13G | CYTOKINETICS INC CYTK | BIOTECHNOLOGY VALUE FUND L P | 2,728,035 3.9% | -4,629,984 (-62.92%) | View |
| 2020-11-16 5:29 pm Purchase | 13G | CYTOKINETICS INC CYTK | BIOTECHNOLOGY VALUE FUND L P | 7,358,019 10.4% | 3,419,739 (+86.83%) | View |
| 2020-04-01 4:53 pm Sale | 13G | CYTOKINETICS INC CYTK | BIOTECHNOLOGY VALUE FUND L P | 3,938,280 6.6% | -3,268,178 (-45.35%) | View |
| 2020-02-14 4:59 pm Purchase | 13G | CYTOKINETICS INC CYTK | Point72 Asset Management L.P. | 3,031,849 5.1% | 46,341 (+1.55%) | View |
| 2020-02-14 4:20 pm Sale | 13G | CYTOKINETICS INC CYTK | GREAT POINT PARTNERS LLC | 160,073 0.27% | -3,013,215 (-94.96%) | View |
| 2020-02-14 3:00 pm Purchase | 13G | CYTOKINETICS INC CYTK | BIOTECHNOLOGY VALUE FUND L P | 7,206,458 12.2% | 3,055,819 (+73.62%) | View |
| 2020-02-12 11:01 am Purchase | 13G | CYTOKINETICS INC CYTK | VANGUARD GROUP INC | 4,545,990 7.68% | 944,078 (+26.21%) | View |
| 2020-02-12 08:13 am Purchase | 13G | CYTOKINETICS INC CYTK | DRIEHAUS CAPITAL MANAGEMENT LLC | 3,039,256 5.14% | 3,039,256 (New Position) | View |
| 2020-02-04 11:52 am Purchase | 13G | CYTOKINETICS INC CYTK | BlackRock Inc. BLK | 9,560,602 16.2% | 834,031 (+9.56%) | View |
| 2020-01-23 5:01 pm Sale | 13G | CYTOKINETICS INC CYTK | INTEGRATED CORE STRATEGIES (US) LLC | 2,571,557 4.3% | -505,398 (-16.43%) | View |
| 2019-12-27 4:37 pm Purchase | 13G | CYTOKINETICS INC CYTK | Point72 Asset Management L.P. | 2,985,508 5% | 2,985,508 (New Position) | View |
| 2019-08-02 4:23 pm Purchase | 13G | CYTOKINETICS INC CYTK | INTEGRATED CORE STRATEGIES (US) LLC | 3,076,955 5.3% | 3,076,955 (New Position) | View |